Open access
Open access
Powered by Google Translator Translator

RCT: Duration of adjuvant aromatase-inhibitor therapy in postmenopausal breast cancer.

30 Jul, 2021 | 11:43h | UTC

Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer – New England Journal of Medicine

 

Commentary on Twitter

 


Stay Updated in Your Specialty

No spam, just news.